Merck & Co.
Dr. Dan Li, PhD, is currently an Associate Principle Scientist in Quantitative pharmacology and pharmacometrics (QP2) group at Merck. She earned her PhD degree from the University of Michigan and then joined Merck as a senior scientist. She has research expericences in antibacterial drug development and her current research focus on clinical pharmacology in cardiovascular and ophthalmology areas. She has been a member of ASCPT since 2018 and has served on the ASCPT infectious disease committee.